A Case of Graves’ Disease Following Vaccination with the Oxford-AstraZeneca SARS-CoV-2 Vaccine: Case Report and Review of the Literature

A Case of Graves’ Disease Following Vaccination with the Oxford-AstraZeneca SARS-CoV-2 Vaccine: Case Report and Review of the Literature

A 57-year-old man presented to the outpatient clinic with tremor, palpitations, weight loss and fatigue 1 week after receiving the first dose of the Oxford-AstraZeneca SARS-CoV-2 vaccine (ChAdOx1 nCoV-19). Laboratory studies showed a suppressed TSH with elevated total and free T4. Thyroid peroxidase...

Full description

Bibliographic Details
Main Authors: Dalia Cuenca, Mercedes Aguilar-Soto, Moises Mercado
Format: Article
Language:English
Published: SMC MEDIA SRL 2022-04-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
graves' disease
astrazeneca
covid-19
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/3275

Internet

https://www.ejcrim.com/index.php/EJCRIM/article/view/3275

Similar Items